ClinicalTrials.gg
Not yet recruitingNCT06381089ERRVNSUpdated Apr 24, 2024

Effect Of Robotic Rehabilitation And Vagus Nerve Stimulation In Ischemia Stroke Patients

An interventional study of Robotic Rehabilitation and Transcutaneous Auricular Vagal Nerve Stimulation in Ischemic Stroke, Vagus Nerve Stimulation and Robotic Rehabilitation, sponsored by SEFA HAKTAN HATIK. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-24.

Sponsored by SEFA HAKTAN HATIK · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 4 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study was conducted in patients with ischemic stroke; This study was conducted to examine the effect of robotic rehabilitation and transcutaneous auricular vagal nerve stimulation applied in addition to robotic rehabilitation on the patient's functional level and autonomic nervous system.

40 people over the age of 18 participated in the study. They were randomly divided into two groups: robotic rehabilitation and transcutaneous auricular vagal nerve stimulation applied in addition to robotic rehabilitation. While the robotic rehabilitation group received Lokomat and neurological rehabilitation, the other group received stimulation with the Vagustim device, which is applied non-invasively through the ear, in addition to Lokomat and neurological rehabilitation. Spasticity, autonomic nervous system, walking speed, motor function, quality of life, muscle activity and pain were evaluated in both groups before starting treatment and six weeks after treatment. In the study, significance was evaluated at p\<0.05 level.

Read the detailed description

A study group was formed, consisting of individuals who had an ischemic stroke over the age of 18, who complied with the research criteria and who signed the voluntary consent form. Age, gender, height, weight, body mass index, dominant side, affected side and time since stroke of the participants who met the inclusion criteria were recorded and randomly divided into 2 groups.

The groups are; They were divided into Robotic Rehabilitation (RRG) (n=20, 11 women, 9 men) and Transcutaneous Auricular Vagal Nerve Stimulation (VRRG) applied in addition to Robotic Rehabilitation (n=20, 9 women, 11 men) groups.

A 6-week protocol was applied in the study. In addition to the neurological rehabilitation program, robotic rehabilitation was applied to the RRG group 2 days a week. In addition to the neurological rehabilitation program, both robotic rehabilitation and transcutaneous auricular vagal nerve stimulation were applied to the VRRG group 2 days a week. Some evaluations were made by the researcher at two different time periods throughout the study. Evaluation times; T0 (before robotic rehabilitation/vagal nerve stimulation application in addition to robotic rehabilitation), T1 (robotic rehabilitation/after vagal nerve stimulation application applied in addition to robotic rehabilitation). These time periods were planned and carried out immediately before the study and after 6 weeks of treatment.

02

Conditions studied

  • Ischemic Stroke
  • Vagus Nerve Stimulation
  • Robotic Rehabilitation
  • Autonomic Nervous System

Browse trials for

Keywords

  • Vagus Nerve Stimulation
  • Transcutaneous
  • Robotic Rehabilitation
  • Ischemic Stroke
  • Superficial EMG
03

In context

Ischemic Stroke

2,612 studies on the registry are indexed under Ischemic Stroke; 971 are open to participants now.

This study's planned enrollment of 40 is below the median of 120 across 1,776 interventional studies indexed under Ischemic Stroke.

Browse Ischemic Stroke studies →

Lead sponsor

SEFA HAKTAN HATIK is the lead sponsor of 14 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being diagnosed with ischemic stroke
  • Having a stroke for the first time
  • Having hemiparesis
  • ≤ 6 months after stroke
  • Being able to walk with or without support
  • Understanding and focusing on Lokomat exercises and being able to do them
  • Having received walking training with Lokomat in our hospital
  • Having signed the voluntary consent form
  • Being over 18 years of age

Exclusion criteria

Exclusion Criteria:

  • Body weight more than 135 kg
  • The person's height is more than two meters
  • Femur length outside the range of 35-47 cm
  • Intolerable leg length differences
  • Peripheral nerve injury
  • Peripheral neuropathy
  • Anticholinergic drug use
  • Presence of skin lesions
  • Spasticity that prevents the locomotive from working
  • Having diagnosed psychiatric problems
  • Severe contracture in lower extremity muscles
  • Not being able to walk before stroke
  • Having a history of additional neurological diseases (Parkinson, etc.)
  • Unstable cardio-pulmonary disease
  • Having orthopedic fractures (lower extremity fractures) and/or joint implants
  • Severe osteoporosis
  • Uncontrolled hypertension despite medication use
  • Lower extremity amputation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Robotic Rehabilitation Group (RRG)

    A 6-week protocol will be applied in the study. In addition to the neurological rehabilitation program, robotic rehabilitation will be applied to the RRG group 2 days a week. Some evaluations will be made by the researcher at two different time periods throughout the study. These time periods will be planned and carried out immediately before the study and after the 6-week treatment.

    Device: Robotic Rehabilitation

  • Experimental
    Vagal Nerve Stimulation With Robotic Rehabilitation Group (VRRG)

    In addition to the neurological rehabilitation program, the VRRG group will receive both robotic rehabilitation and t-VNS 2 days a week. Some evaluations will be made by the researcher at two different time periods throughout the study. These time periods will be planned and carried out immediately before the study and after the 6-week treatment.

    Device: Robotic Rehabilitation · Device: Transcutaneous Auricular Vagal Nerve Stimulation

Interventions

  • DeviceRobotic Rehabilitation

    Lokomat is an exoskeleton type robotic walking device that can support both extremities symmetrically.

  • DeviceTranscutaneous Auricular Vagal Nerve Stimulation

    Vagus nerve stimulation is defined as any technique that stimulates the vagus nerve in our body.

06

What researchers measure

Primary outcomes

  1. Numerical Pain Rating Scale

    Numerical pain scale is used to classify pain from 0 to 10. '0' means no pain and '10' means unbearable pain.

    Time frame: Time Frame: within 10 minutes after intervention

  2. Stroke Specific Quality of Life Scale

    The stroke-specific quality of life scale consists of a total of 49 items in 12 domains. Each item is scored between 1 (strongly agree) and 5 (strongly disagree). The total score is evaluated between 49 and 245 points. A score of 49 indicates the lowest quality of life and 245 indicates the highest quality of life.

    Time frame: Time Frame: within 10 minutes after intervention

  3. 10 Meter Walk Test

    During the test, the patient's walking performance is recorded in terms of time between two markers located 10 meters apart. It is used to determine functional mobility and walking speed.

    Time frame: Time Frame: within 10 minutes after intervention

  4. Fugl-Meyer Assessment Lower Extremity

    It is a widely used scale in the evaluation of motor function after stroke. The lower extremity section consists of 17 items and its maximum score is 34 points.

    Time frame: Time Frame: within 10 minutes after intervention

  5. Modified Ashworth Scale

    It is the universally accepted clinical tool used to measure increases in muscle tone.

    Time frame: Time Frame: within 10 minutes after intervention

  6. Electromyography

    It refers to the collective electrical signals during the contraction of muscles connected to the nervous system. EMG devices evaluate and interpret the electrical potential that enables the contraction of voluntary muscles. The EMG device evaluates voluntarily working skeletal muscles. EMG, a muscle examination, monitors and interprets the electrical activity that causes muscles to contract. EMG examinations are defined as a set of tests that include nerve examination as well as examination of muscle activation.

    Time frame: Time Frame: within 10 minutes after intervention

  7. Autonomic Nervous System

    The Polar H10 device is a gold-standard HRV sensor of high sensitivity and accuracy that comes with a wearable chest strap. The device comes with a soft, adjustable sensor that contacts the chest to capture HRV in real time.

    Time frame: Time Frame: within 10 minutes after intervention

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06381089
Lead sponsor
SEFA HAKTAN HATIK
Responsible party
SEFA HAKTAN HATIK (Assistant Professor, Sinop University) — Sponsor-investigator
First posted
Apr 24, 2024
Start date
May 10, 2024 (estimated)
Primary completion
Jul 10, 2024 (estimated)
Completion
Aug 10, 2024 (estimated)
Last update
Apr 24, 2024

Study contacts

Sefa Haktan HATIK, PhD
Contact
haktanhtk@gmail.com
00905058761533
SEFA HAKTAN HATIK, PhD
study chair · Sinop University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion